ZLAB Q1 2024 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$87M+38.8% YoY

Gross Profit

$54M61.4% margin

Operating Income

-$70M-80.7% margin

Net Income

-$53M-61.4% margin

EPS (Diluted)

$-5.50

QoQ Revenue Growth

+32.4%

Cash Flow

Operating Cash Flow

-$90M

Free Cash Flow

-$103M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$988M

Total Liabilities

$226M

Stockholders' Equity

$762M

Cash & Equivalents

$651M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$63M	+38.8%
Gross Profit	$54M	$41M	+29.1%
Operating Income	-$70M	-$70M	-1.1%
Net Income	-$53M	-$49M	-8.8%

Revenue Segments

Zejula

$46M61%

Optune

$12M17%

Nuzyra

$10M13%

Qinlock

$6M8%